Abbott Medical - VERITAS Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 458 participants.

Also called NCT06707688

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 458 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT06707688
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Belgium, Canada, Denmark, France, Germany, Italy, Spain, Switzerland (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT06707688. Allocation not applicable; no masking; primary purpose treatment. Start 2024-11-07 (actual); primary completion 2025-11-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Abbott Medical - VERITAS Study
Condition
Atrial Fibrillation (AF)
Condition
Stoke
Intervention (Device)
Amulet™ 2 Left Atrial Appendage (LAA) Occluder
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct06707688
Content hash
e53cff176883a98fae63e49ccca2c719b637c36623c71ba0bbfd64feaba5c7ac